Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06408155
Other study ID # DINOGMI-2024
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 13, 2024
Est. completion date June 6, 2024

Study information

Verified date June 2024
Source Universita degli Studi di Genova
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study employed a randomized crossover design to assess the impacts of three different experimental conditions-standard environment, music, and verbal encouragement-on performance in an isometric endurance task, with comparisons made between untrained and trained individuals. Interventions were spaced seven days apart. Measurements included muscle activity and fatigue, assessed via surface electromyography, and the duration of the task. The isometric endurance task required participants to maintain a 90° elbow flexion while holding a dumbbell in a supine grip, weighted to 80% of their one-repetition maximum, on the dominant side. During the task, participants were to keep their back and head against a vertical wall, stand with feet shoulder-width apart, and firmly on the ground. The dumbbell was held with the dominant arm, and the other arm was kept neutral by the side. It was crucial to avoid any rocking or movements that would ease maintaining the position. The test began when the bar was handed to the participant in the correct stance and concluded once the arm's angle deviated by more than five degrees from the start.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date June 6, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 40 Years
Eligibility Inclusion Criteria: - Good general health, - No medical conditions that could interfere with their ability to perform the test safely and effectively. - To be considered exercised, participants had to have performed 150 minutes per week of vigorous intensity aerobic physical activity, in addition to muscle strengthening activities, for at least two days per week. Those who did not meet this standard were considered untrained. Exclusion Criteria: - History of surgery on the arm, shoulder or adjacent areas that could limit the ability to perform the test. - Use of medication that affects muscle function or pain perception

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Isometric Task
The task demanded that participants maintain their arm bent at a 90° angle while holding a dumbbell, which weighed 80% of their one-repetition maximum (1RM), in a supine grip on the dominant side of their body for the longest time they could.

Locations

Country Name City State
Italy Università degli Studi di Genova Genova

Sponsors (1)

Lead Sponsor Collaborator
Universita degli Studi di Genova

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of the task task duration expressed in seconds Through task completion, an average of sixty seconds
Primary Neuromuscular excitation of Biceps Brachii Amplitude of electromyography value (Root Mean Square in microvolt) measured for Biceps Brachii muscle Through task completion, an average of sixty seconds
Primary Neuromuscular excitation of Brachioradialis Amplitude of electromyography value (Root Mean Square in microvolt) measured for Brachioradialis muscle Through task completion, an average of sixty seconds
Primary Neuromuscular fatigue of Biceps Brachii Time-course evolution of the Median Frequency of the Power Density Spectrum (MF Hz) of the electromyography signal measured for biceps brachii muscle Through task completion, an average of sixty seconds
Primary Neuromuscular fatigue of Brachioradialis Time-course evolution of the Median Frequency of the Power Density Spectrum (MF Hz) of the electromyography signal measured for Brachioradialis muscle Through task completion, an average of sixty seconds
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1